10x Genomics(TXG)
Search documents
Torex Gold Provides Q4 2024 Update on Media Luna Project
Newsfile· 2025-02-04 23:00
Torex Gold Provides Q4 2024 Update on Media Luna ProjectConstruction substantially complete and first copper concentrate on track for MarchFebruary 04, 2025 6:00 PM EST | Source: Torex Gold Resources Inc.(All amounts expressed in U.S. dollars unless otherwise stated)Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides a Q4 2024 update on the development of its Media Luna Project ("Media Luna"). Unless otherwise stated, ...
10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
Prnewswire· 2025-01-28 21:05
PLEASANTON, Calif., Jan. 28, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2024 after market close on Wednesday, February 12, 2025. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release ...
Torex Gold Provides 2025 Operational Guidance and Updated Five-Year Production Outlook
Newsfile· 2025-01-14 23:00
Torex Gold Provides 2025 Operational Guidance and Updated Five-Year Production OutlookOn track to return to positive free cash flow mid-year as Media Luna ramps upJanuary 14, 2025 6:00 PM EST | Source: Torex Gold Resources Inc.(All amounts expressed in U.S. dollars unless otherwise stated)Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides 2025 operational guidance as well as an updated five-year production outlook fo ...
10x Genomics(TXG) - 2024 Q4 - Annual Results
2025-02-12 21:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K ______________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2025 10x Genomics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) Delaware 001-39035 45-5614458 (Commission File Number) (IRS Employer Identification No.) Washington, D.C. 20549 ______________________ 6230 Stoneridge Mall R ...
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
Prnewswire· 2025-01-12 17:00
Company Performance - The company reported preliminary, unaudited FY 2024 revenue of approximately $611 million and Q4 2024 revenue of approximately $165 million, representing 9% sequential growth [4] - Q4 2024 revenue of $165 million showed a 10% decrease compared to the corresponding prior year period [10] - FY 2024 revenue of $610.8 million represented a 1% decrease from the prior year [10] - The company's cumulative instruments sold increased to over 7,000 by the end of 2024, including over 5,800 Chromium instruments, over 800 Visium instruments, and over 400 Xenium instruments [10] - Cash, cash equivalents, and marketable securities stood at approximately $393 million as of December 31, 2024 [10] Revenue Breakdown - Q4 2024 instruments revenue was approximately $24.4 million, showing 28% sequential growth but a 37% decrease compared to the prior year period [10] - Q4 2024 consumables revenue was approximately $133.5 million, with 6% sequential growth but a 5% decrease compared to the prior year period [10] - Q4 2024 services revenue was approximately $7.1 million, showing 12% sequential growth and 35% growth over the prior year period [10] - FY 2024 instruments revenue was approximately $92.7 million, a 25% decrease from the prior year [10] - FY 2024 consumables revenue was approximately $493.4 million, representing 3% growth over the prior year [10] - FY 2024 services revenue was approximately $24.6 million, showing 57% growth over the prior year [10] Product-Specific Revenue - Q4 2024 Chromium instruments revenue was approximately $10.9 million, while Spatial instruments revenue was approximately $13.4 million [10] - Q4 2024 Chromium consumables revenue was approximately $97.7 million, while Spatial consumables revenue was approximately $35.8 million [10] - FY 2024 Chromium instruments revenue was approximately $35.2 million, while Spatial instruments revenue was approximately $57.5 million [10] - FY 2024 Chromium consumables revenue was approximately $372.3 million, while Spatial consumables revenue was approximately $121.1 million [10] Company Overview - The company is a life science technology firm focused on accelerating the mastery of biology and advancing human health [7] - Its integrated solutions include instruments, consumables, and software for single cell and spatial biology [7] - The company's products support breakthroughs in oncology, immunology, neuroscience, and other fields [7] Investor Relations - The company will participate in the 43rd Annual J P Morgan Healthcare Conference, with a live webcast available on January 13, 2025 [1] - The company discloses material non-public information through SEC filings, its website, press releases, conference calls, webcasts, and social media accounts [3]
Torex Gold Delivers on Full-Year Production Guidance
Newsfile· 2025-01-08 23:00
Torex Gold Delivers on Full-Year Production Guidance2024 marks the sixth consecutive year production guidance has been achievedJanuary 08, 2025 6:00 PM EST | Source: Torex Gold Resources Inc.Toronto, Ontario--(Newsfile Corp. - January 8, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports fourth quarter gold production of 103,795 ounces ("oz") and full-year gold production of 452,523 oz, within the Company's revised guidance range of 450,000 to 470,000 oz (original ...
Torex Gold to Restart Operations and Project Activities at the Morelos Complex
Newsfile· 2024-12-17 21:57
Toronto, Ontario--(Newsfile Corp. - December 17, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports that the Director General of Mines under the Federal Ministry of Economy has lifted the temporary suspension notice and allowed for all activities within the Morelos Complex to resume.Jody Kuzenko, President & CEO of Torex, stated:"Following notification that the temporary suspension has been lifted by the Director General of Mines, all production and development activities at th ...
Torex Gold Reports Three Fatalities at the ELG Underground Mine
Newsfile· 2024-12-05 23:30
Group 1 - Torex Gold Resources Inc. reported a tragic incident at the El Limón Guajes underground mine, resulting in the deaths of two employees and one contractor due to carbon monoxide exposure [1][2] - A fourth contract employee is hospitalized but is expected to recover; the company is prioritizing support for the affected families and employees [2] - An investigation into the cause of the accident will be initiated, and all activities at the ELG Underground have been suspended [2] Group 2 - Torex Gold is an intermediate gold producer based in Canada, focusing on the exploration, development, and operation of its 100% owned Morelos Property, which spans 29,000 hectares in the Guerrero Gold Belt [3] - The Morelos Complex, the company's principal asset, includes the ELG Mine Complex and the Media Luna Project, with commercial production starting on April 1, 2016 [3] - Key strategic objectives for Torex include optimizing the Morelos Property, achieving full production at Media Luna, growing reserves, disciplined capital allocation, and enhancing ESG excellence [3]
Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling Program
Newsfile· 2024-12-02 23:00
Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling ProgramResults continue to indicate impressive grades and ongoing potential to expand resources and replace mined reservesDecember 02, 2024 6:00 PM EST | Source: Torex Gold Resources Inc.(All amounts expressed in U.S. dollars unless otherwise stated)Toronto, Ontario--(Newsfile Corp. - December 2, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces further assay results from the Compan ...
Torex Gold Reports Results From The Ongoing 2024 EPO Exploration Program
Newsfile· 2024-11-13 23:00
Torex Gold Reports Results From The Ongoing 2024 EPO Exploration ProgramResults indicate strong potential to upgrade Inferred Resources to Indicated Resources and expand resources to the north of the depositNovember 13, 2024 6:00 PM EST | Source: Torex Gold Resources Inc.(All amounts expressed in U.S. dollars unless otherwise stated)Toronto, Ontario--(Newsfile Corp. - November 13, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces assay results from the Company's ...